-
Response to Vincenzi et al. on: ‘Real‐world treatment burden of BV‐based frontline regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma’
Eldad J. Dann, Tzvika Porges, Tsofia Levi
British Journal of Haematology
· Гематология
· 2026-11-20
-
CAR‐T cells in first relapse of paediatric Down syndrome B‐cell acute lymphoblastic leukaemia: Oncologist perspectives
Jeremy D. Rubinstein,
Colleen Annesley,
Deepa Bhojwani,
Sara Ghorashian,
Johann Hitzler,
Rishi S. Kotecha,
Joerg Krueger,
Susana Rives,
Anupam Verma,
Sara Zarnegar‐Lumley,
Nirali N. Shah,
Karen R. Rabin
British Journal of Haematology
· Гематология
· 2026-11-20
-
Nodular immunoglobulin‐associated pulmonary amyloidosis with extensive osseous metaplasia
Natasha E. Lewis, Henry D. Tazelaar
British Journal of Haematology
· Гематология
· 2026-11-20
-
Even a worm may turn: Opportunistic strongyloides hyperinfection
Stephen Sze‐Yuen Lam,
Garret Man‐Kit Leung,
Michael Yuey‐Zhun Ng,
Yok‐Lam Kwong
British Journal of Haematology
· Гематология
· 2026-11-20
-
VEXAS syndrome with UBA1 p.Ser56Phe in a 46,XX woman
Benjamin Lebecque,
Thomas Tassin,
Lauren Veronese,
Olivier Kosmider,
Benjamin Terrier,
Ludovic Trefond
British Journal of Haematology
· Гематология
· 2026-11-20
-
Real‐world treatment burden of brentuximab vedotin‐based front‐line regimens in young adults and adults with advanced‐stage classical Hodgkin lymphoma
Annamaria Vincenzi, Marco Picardi, Claudia Giordano, Novella Pugliese, Sara Pellegrino, Fabrizio Pane
British Journal of Haematology
· Гематология
· 2026-11-19
-
Haematological malignancies in paediatric and adolescents or young adults patients with Li‐Fraumeni syndrome: Retrospective multi‐institutional case series
Yoshiko Nakano, Keisuke Kato, Yuichi Mitani, Yuki Arakawa, Hidetaka Niizuma, Yoji Sasahara, Shinya Osone, Toshihiko Imamura, Misato Suzuki, Daisuke Hasegawa, Dai Keino, Eiji Nakata, Ryoji Kobayashi, Ryo Maemura, Nao Yoshida, Michio Ozeki, Moe Hidaka, Hiroyoshi Hattori, David Malkin, Motohiro Kato
British Journal of Haematology
· Гематология
· 2026-11-18
-
Estimated pulse wave velocity in ET and PV: A biologically plausible risk marker awaiting prospective validation
Bisma Khan, Mubashir Anjum Malik, Wamiq Saeed
British Journal of Haematology
· Гематология
· 2026-11-18
-
Complex karyotype and non‐BTK driver mutations associated with BTK inhibitor resistance in chronic lymphocytic leukaemia
Kiyomi Mashima,
Stacey M. Fernandes,
Mariia Mikhaleva,
Roberta Santos Azevedo,
Stephen Martindale,
Binu Kandathilparambil Sasi,
Saurabh Yadav,
Uday Aditya Sarkar,
Rayan Fardoun,
Xinhao Sun,
Colin McNulty,
Ava M. Kominski,
Paige R. Fitzgerald,
Ava Bidgoli,
Paulina Predko,
Samantha Shupe,
John‐Hanson Machado,
Aishath Naeem,
Inhye E. Ahn,
Matthew S. Davids,
Jennifer R. Brown
British Journal of Haematology
· Гематология
· 2026-11-17
Summary We retrospectively analysed 646 chronic lymphocytic leukaemia (CLL) patients treated with Bruton tyrosine kinase inhibitors (BTKis) at Dana‐Farber Cancer Institute from 2014 to 2023. Among them, 122 underwent next‐generation...
-
Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease
Gloria F. Gerber,
Sacha Choupa,
Amy Luo,
Vinal Menon,
Nadine Shehata,
Jayla Scott,
Macy L. E. Gatti,
Michael B. Streiff,
Rakhi P. Naik,
Kevin Kuo,
A. Kinga Malinowski,
Lydia H. Pecker
British Journal of Haematology
· Гематология
· 2026-11-17
Summary Sickle cell disease (SCD) is a thrombophilia exacerbated by pregnancy. However, there is not strong evidence for thromboprophylaxis, perhaps because most data addressing pregnancy‐related thrombosis in SCD is limited by...
-
Practical Transfusion Medicine7th Edition Edited by Michael F. Murphy, Nancy M. Dunbar and Erica M. Wood, Wiley. 2026. ISBN‐10: 1394291965
Sue Pavord,
Julie Staves
British Journal of Haematology
· Гематология
· 2026-11-17
-
Spatial and transcriptomic analyses reveal the adverse prognostic impact of regulatory T cells in follicular lymphoma treated with rituximab–lenalidomide
Camille Laurent,
Marie Tosolini,
Arnaud Guille,
Bruno Tesson,
Nathalie Van‐Acker,
François‐Xavier Frenois,
Andrea Belin‐Artola,
Bastien Lesne,
Pierre Brousset,
BIDIFLY Consortium,
Franck Morschhauser,
Luc Xerri,
Guillaume Cartron,
Yassine Al‐Tabaa,
Clara Antoine,
Matthieu Blons,
Anne‐Laure Borrel,
Irène Buvat,
Florian Carlessi,
Loic Chartier,
Michel Cogné,
Marie‐Hélène Delfau‐Larue,
Laetitia Fuhrmann,
Hervé Ghesquières,
Salim Kanoun,
Camille Laurent,
Léa Marlot,
Franck
British Journal of Haematology
· Гематология
· 2026-11-17
Summary The prognostic impact of the tumour microenvironment in follicular lymphoma (FL) remains controversial. To adress this, we analysed FL samples from patients enrolled in the rituximab lenalidomide versus any chemotherapy...
-
A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
Victor Tellez,
Anirvin Bommaraju,
Jamie Cheung,
Regina Swift,
Jonathan Moore,
Pierre Sayad,
Frank Pezzullo,
Aaron Gette,
Alex Wright,
Jon Hall,
Randall Noval,
Blake Morrison,
James R. Berenson
British Journal of Haematology
· Гематология
· 2026-11-16
Summary Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility...
-
CD20 antigen loss post‐venetoclax/anti‐CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications
Tamasine Stewart,
Sean McKeague,
Divya Somasekharannair,
Lei‐Shong Lau,
Ashley Whitechurch,
Joshua Casan,
Neil Came,
Kylie Baldwin,
Vuong Nguyen,
Ing Soo Tiong,
Sean Harrop,
Mary Ann Anderson,
John F. Seymour,
David Westerman,
Philip A. Thompson,
Kah Lok Chan
British Journal of Haematology
· Гематология
· 2026-11-16
Summary Venetoclax plus anti‐CD20 monoclonal antibody (mAb) regimens have revolutionised treatment for chronic lymphocytic leukaemia (CLL); however, CD20 antigen loss is a potential consequence. Given emerging roles for re‐treatment...
-
Correction to ‘Risk factors and reasons for switching from front‐line therapy in the Italian chronic myeloid leukaemia network: A cohort study’
British Journal of Haematology
· Гематология
· 2026-11-16
-
Caregiver support in patients with plasma cell dyscrasias: A novel single‐item pilot measure of caregiver availability: Results from a survey of >1000 patients
Ghulam Rehman Mohyuddin,
Mason Barnes,
Craig Cole,
Nadine Abdallah,
David Barton,
Beth Travis,
Jorge Arturo Hurtado Martinez,
Jennifer Ahlstrom,
Alex Brown,
Rachel Jensen,
Felipe Flores Quiroz,
Jael Antonio Liñán Esparza,
Jay Hydren
British Journal of Haematology
· Гематология
· 2026-11-13
Summary Treatment for plasma cell dyscrasias imposes burdens on patients and caregivers, particularly for cellular therapies. Traditional social determinants of health may not capture caregiver availability. We conducted a...
-
Response to: Comment on ‘Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6‐related thrombocytopenia’
Ivan P. Tesakov
British Journal of Haematology
· Гематология
· 2026-11-12
-
Comment on ‘Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6‐related thrombocytopenia’
Maajid Mohi Ud Din Malik, Abhay Saraf, Rajesh Prasad Jayaswal
British Journal of Haematology
· Гематология
· 2026-11-12
-
Clinical phenotypes, autoimmunity and outcomes in Rosai–Dorfman disease: An international multicentre cohort study
Mitali Sen,
Gordon J. Ruan,
Samuel B. Reynolds,
Haadi Ali,
Xi Yang,
Diana Morlote,
Aishwarya Ravindran,
Lauren Shea,
Matthew J. Koster,
Jithma P. Abeykoon,
Hind Salama,
Xin‐Xin Cao,
Asra Z. Ahmed,
Ronald S. Go,
Gaurav Goyal
British Journal of Haematology
· Гематология
· 2026-11-11
Summary Rosai–Dorfman disease (RDD) is a rare histiocytic neoplasm with diverse clinical behaviour and immune abnormalities with unknown clinical significance. We performed a retrospective cohort study of 162 patients with RDD from 2003...
-
Indole‐3‐lactic acid ameliorates thrombocytopenia in primary immune thrombocytopenia by modulating the differentiation of Th17 and Tregs
Yanxia Zhan,
Pu Chen,
Lili Ji,
Hao Pang,
Dongmei Luo,
Pengcheng Xu,
Yunan ling,
Luya Cheng,
Hao Chen,
Yunfeng Cheng
British Journal of Haematology
· Гематология
· 2026-11-11
Summary Although some patients with primary immune thrombocytopenia (ITP) benefit from current treatments, there are still some refractory patients. Our previous research showed that the imbalance of the intestinal microbiota is...
-
NPM1‐mutated AML: One entity, multiple layers of heterogeneity
Manja Meggendorfer,
Wolfgang Kern
British Journal of Haematology
· Гематология
· 2026-11-11
Nucleophosmin 1 ( NPM1 ) mutations are found in around one third of all acute myeloid leukaemias (AMLs). However, little is known about the clinical role of the rare, non‐A NPM1 variants. Sangiorgio et al. showed that rare variants...
-
Rare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia
Valentina Sangiorgio, Alberto Hernández‐Sánchez, Rocco Piazza, Monica Fumagalli, Lars Bullinger, Carlo Gambacorti‐Passerini, Mariarita Sciumè, Nicola Fracchiolla, Daniele Ramazzotti
British Journal of Haematology
· Гематология
· 2026-11-11
-
Orelabrutinib plus R‐CHOP in patients with newly diagnosed non‐GCB double‐expressor DLBCL: A single‐arm, phase II study
Yang Yang,
Yi Zhao,
Wenjun Wu,
Gaofeng Zheng,
Donghua He,
Li Yang,
Yi Li,
Fuming Zi,
Fengping Zhou,
Cai Wu,
Jingsong He,
Zhen Cai
British Journal of Haematology
· Гематология
· 2026-11-10
Summary Double‐expressor diffuse large B‐cell lymphoma (DE‐DLBCL) patients, defined by co‐expression of MYC proto‐oncogene protein (≥40%) and B‐cell lymphoma 2 protein (≥50%), typically have poor outcomes with the traditional first‐line...
-
Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)
Miles Thomas, Apoorva Ravichandran, Emily Dworkin, Caner Saygin, Adam DuVall, Wendy Stock, Anand A. Patel
British Journal of Haematology
· Гематология
· 2026-11-10
-
Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification—Insights from chromosome count and cytogenetic abnormalities
Zhao Zeng,
Jiao Lu,
Jingjing Shang,
Hongyin You,
Qingrong Wang,
Lijun Wen,
Qian Wang,
Wanhui Yan,
Chunxiao Wu,
Panfeng Wang,
Lian Bai,
Song Jin,
Lingzhi Yan,
Suning Chen,
Depei Wu,
Jinlan Pan,
Chengcheng Fu
British Journal of Haematology
· Гематология
· 2026-11-10
-
A pro‐inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation
Catherine B. Ducker,
Megan V. Preece,
Jeremy Schofield,
Charis Pericleous,
Mike Laffan,
Simon Abrams,
Deepa J. Arachchillage
British Journal of Haematology
· Гематология
· 2026-11-10
-
Comparison of venetoclax and azacitidine versus a cytarabine‐based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real‐world study of the DATAML‐IPC‐AURAML consortium
Pierre‐Yves Dumas,
Sarah Bertoli,
Emilie Bérard,
Clémence Santana,
Maël Heiblig,
Thibaut Leguay,
Suzanne Tavitian,
Estelle Borgne,
Anne‐Charlotte de Grande,
Audrey Sarry,
Ziyad Acheaibi,
Laetitia Largeaud,
Morgane Sighieri,
Emilie Klein,
Emmanuelle Tavernier,
Marie‐Anne Hospital,
Martin Carré,
Gaspar Aspas Requena,
Anne Banos,
Norbert Vey,
Arnaud Pigneux,
Christian Récher,
Sylvain Garciaz
British Journal of Haematology
· Гематология
· 2026-11-10
-
Evaluation of the UK Myeloma Research Alliance risk profile in transplant‐ineligible multiple myeloma patients treated with novel agents
Hitomi Nakayama,
Tomonori Nakazato,
Atsushi Takahata,
Eriko Sato,
Maho Kawakami,
Keigo Okada,
Takashi Abe,
Toshiaki Hayashi,
Kohtaro Toyama,
Yasutaka Senpuku,
Masaru Nakagawa,
Motoki Takano,
Keisuke Tanaka,
Yuki Osada,
Junichi Watanabe,
Koh Yamamoto,
Yasunobu Sekiguchi,
Gaku Oshikawa,
Yuta Kimura,
Michihide Tokuhira,
Ken Suzuki,
Takayuki Ikezoe,
Noriyoshi Iriyama,
Katsuhiro Miura,
Takashi Kumagai,
Shigeo Toyota,
Takehiko Mori
British Journal of Haematology
· Гематология
· 2026-11-10
-
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study
Stefano Luminari, Maria Elena Nizzoli, Michele Merli, Sara Rattotti, Vittoria Tarantino, Simone Ferrero, Annalisa Talami, Roberta Murru, Marina Deodato, Emanuele Cencini, Giovanni Roti, Carlo Visco, Guilherme Duffles, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés José María Ferreri, Caterina Stelitano, Elsa Pennese, Emiliano Barbieri, Marzia Varettoni, Gambara Silvia, Marta Coscia, Dario Marino, Tisi Maria Chiara, Maher Nawar, Luigi Marcheselli, Francesco Merli, Luca Arcaini
British Journal of Haematology
· Гематология
· 2026-11-10
-
Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests
Mathilde Egelund Christensen,
Michael Charles Sachs,
William Grant Dunn,
Gustav Jonzon,
Margit Kriegbaum,
Bent Struer Lind,
Jan Samuelsson,
Kirsten Groenbaek,
George Vassiliou,
Christen Lykkegaard Andersen
British Journal of Haematology
· Гематология
· 2026-11-10